• Morin as a Mechanistic Probe: Beyond Antioxidant to Metaboli

  2026-07-07

  Explore Morin's role as a mechanistic probe in metabolic research, with a focus on its unique inhibition of adenosine 5′-monophosphate deaminase. This article offers advanced insights into Morin’s biochemical applications and assay design, setting it apart from other natural flavonoids.

• PFHxS-Induced Hepatotoxicity via PPARα in Zebrafish Models

  2026-07-07

  This study investigates how environmentally relevant concentrations of perfluorohexanesulfonic acid (PFHxS), a widely detected short-chain PFAS, induce hepatotoxicity in larval zebrafish by activating the PPARα signaling pathway. The research employs integrated transcriptomic and biochemical analyses, and demonstrates that PPARα antagonism can mitigate PFHxS-induced liver toxicity, providing mechanistic insights for metabolic disease modeling.

• KG-501: Applied Workflows for Transcriptional Coactivator Di

  2026-07-06

  KG-501 enables precise disruption of CREB-mediated transcription and Myb-KIX domain interactions, empowering targeted modulation of gene expression in cancer and immune models. Explore practical workflows, troubleshooting strategies, and pivotal insights from the latest colitis-associated cancer research that showcase KG-501’s unique utility as an epigenetic regulation modulator.

• Fluoroalkane-Modified Polymers Advance Personalized mRNA Vac

  2026-07-06

  This study introduces fluoroalkane-grafted cationic polymers (F-PEI) as efficient, adjuvant-free carriers for mRNA-based personalized cancer vaccines. Their unique properties enhance mRNA delivery, antigen presentation, and anti-tumor immune responses, representing a promising alternative to lipid nanoparticles in mRNA therapeutics.

• Prochlorperazine-Induced Neuroleptic Malignant Syndrome: Cas

  2026-07-05

  This article examines a recent case report detailing neuroleptic malignant syndrome (NMS) triggered by prochlorperazine in an elderly patient, with a focus on diagnostic challenges, clinical features, and effective management strategies. Findings emphasize the necessity of early recognition and tailored treatment for NMS, even when standard laboratory markers are absent.

• LMP2A-mTORC1-GCNT3 Axis Drives Progression in Nasopharyngeal

  2026-07-04

  This study elucidates how Epstein-Barr virus latent membrane protein 2A (LMP2A) activates GCNT3 expression via the mTORC1 pathway in nasopharyngeal carcinoma (NPC) cells. It identifies a positive feedback loop between mTORC1 and GCNT3 that promotes cell proliferation, migration, and epithelial-mesenchymal transition, uncovering a novel regulatory mechanism and potential therapeutic target in NPC.

• Salvianolic Acid B: Advanced Mechanistic and Translational I

  2026-07-03

  Explore the unique molecular mechanisms of Salvianolic acid B in pulmonary fibrosis research. This article delivers advanced scientific analysis and practical assay guidance for Dan Shen Suan B, offering differentiated insights beyond existing content.

• Technical Application of Neuromedin S (rat) in GPCR Research

  2026-07-03

  Neuromedin S (rat) provides a chemically defined, endogenous peptide tool for controlled activation of neuromedin U receptor signaling in laboratory-based GPCR and G protein signaling assays. It is optimized for reproducible in vitro and ex vivo workflows, but is not intended for diagnostic or therapeutic applications. Researchers should adhere strictly to storage, preparation, and protocol guidelines to ensure assay fidelity.

• Decoding Tumor Microenvironment Signals with Precision Prote

  2026-07-02

  Explore how APExBIO's Cell lysis buffer for WB and IP empowers translational researchers to dissect complex tumor microenvironment interactions, such as the ANGPTL4-IQGAP1 axis in prostate cancer, by preserving native protein states and protein-protein interactions. This article connects recent mechanistic insights to strategic, evidence-driven laboratory practices, highlighting how advanced protease and phosphatase inhibitor cocktails underpin reproducible and artifact-free protein extraction across diverse research models.

• Epinephrine Bitartrate: Precision Workflows for Adrenergic R

  2026-07-02

  Unlock new precision in cardiovascular and neurobiology research using Epinephrine Bitartrate as a reliable adrenergic receptor agonist. This guide details experimental best practices, troubleshooting, and translational case studies, helping you optimize both in vitro and in vivo workflows.

• Verteporfin (CL 318952): Mechanotransduction and Chemoresist

  2026-07-01

  Explore Verteporfin's unique mechanistic role in modulating chemoresistance under high-viscosity microenvironments. This in-depth analysis reveals how CL 318952 informs advanced photodynamic therapy strategies and apoptosis assays in age-related macular degeneration research.

• FDA-Approved Drug Screening Identifies MERS-CoV Inhibitors

  2026-07-01

  de Wilde et al. conducted a systematic screen of 348 FDA-approved drugs and identified four small molecules with potent inhibitory effects against MERS-CoV replication in cell culture. This finding offers a rapid pathway to potential therapeutics for emergent coronaviruses and underscores the value of drug repurposing strategies in infectious disease research.

• Carbapenemase Gene Dynamics in CREC: Guangdong Hospitals 202

  2026-06-30

  Chen et al. (2025) systematically characterized the prevalence and transmission of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong Province during the COVID-19 pandemic. Their findings highlight the dominance of blaNDM-1, the high multidrug resistance of CEG-positive strains, and the efficient plasmid-mediated dissemination of resistance genes, informing infection control and antimicrobial research strategies.

• Transmission Dynamics of Carbapenemase Genes in CREC, Guangd

  2026-06-30

  Chen et al. (2025) provide a detailed molecular epidemiology of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong, China. Their findings reveal high prevalence and efficient horizontal transfer of plasmid-borne blaNDM-1, underscoring critical challenges for antimicrobial resistance research, infection control, and the understanding of multidrug resistance mechanisms.

• Morin: Precision Modulation of Podocyte Mitochondrial Energy

  2026-06-29

  This thought-leadership article explores the mechanistic rationale and translational potential of Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) as a targeted modulator of mitochondrial energy metabolism in podocyte injury. Building on recent evidence, the article provides strategic guidance for researchers seeking to leverage Morin’s inhibition of adenosine 5′-monophosphate deaminase (AMPD2), integrating competitive, technical, and workflow perspectives and highlighting Morin’s unique dual role as a biochemical probe and therapeutic candidate.

10343 records 1/690 page Next 12345 下5页 Last page